Two July 2026 NAD+ Trials: Raising Blood NAD+ Is the Easy Part
An NR pilot in mild cognitive impairment doubled blood NAD+ without improving cognition; an oral NAD+ formulation raised intracellular NAD+ in six days.
Tagged
nad-plus
5 notes in this topic
What Is NAD+? Cellular Energy, Sirtuins and the Research Record
A plain-language guide to NAD+: what it does in redox metabolism and signaling, why it declines with age, and what human and animal studies have shown.
NMN vs. NR vs. NAD+: Precursors and the Direct Molecule Compared
How nicotinamide mononucleotide, nicotinamide riboside and NAD+ itself differ in structure, uptake, human evidence and regulatory status.
Neuroprotective Peptides: An Overview of the Research Landscape
A map of the peptide classes studied for neuroprotection, melanocortin fragments, incretins, neurotrophin mimetics, mitochondrial peptides, and how each fared.
Amino Acids vs. Peptides vs. Proteins: Where the Lines Are Drawn
Amino acids, peptides and proteins form one continuum of chemistry. This note explains where the working boundaries sit and why they matter in the laboratory.
All content in the research library is educational and intended for qualified researchers. Products referenced are for laboratory research use only and are not approved for human or veterinary use. Nothing here is medical advice.